Parallax Volatility Advisers’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
DGM
OM
Parallax Volatility Advisers's TGTX Position: Q3 2023 in Review
Parallax Volatility Advisers sold out of TG Therapeutics (TGTX) in Q3 2023, closing a stake of 22,303 shares — an estimated $311K sold.
Parallax Volatility Advisers first reported a position in TGTX in Q4 2015 and held it in 12 quarters. The position peaked at $1.49M in Q3 2021. 236 funds tracked by Wall St. Rank hold TGTX as of Q3 2023.
- Parallax Volatility Advisers reported no remaining TG Therapeutics position as of Q3 2023 after selling out during the quarter.
- Parallax Volatility Advisers sold 22,303 TG Therapeutics shares in Q3 2023, an estimated $311K.
- Parallax Volatility Advisers first reported a position in TG Therapeutics in Q4 2015 and held it in 12 quarters.
- Parallax Volatility Advisers's TG Therapeutics position peaked at $1.49M in Q3 2021.
- 236 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2023.
Based on Parallax Volatility Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.